25.01.2017 • Topics

Azelis to Distribute Angus’ Portfolio of Nitroalkanes in Europe

Angus Chemical Company announced an arrangement with Azelis as part of its new distribution strategy for the company’s complete portfolio of nitroalkanes and their derivatives sold in Europe. The Belgian specialty chemicals distributor has been appointed as a distribution partner, effective Jan. 1, 2017. The partnership includes the biotechnology market on a pan-European basis (including Turkey, and excluding Finland, Lithuania, Latvia and Estonia until April 1, 2017) and paints, coatings and other industrial markets for France, Belgium, The Netherlands and Luxembourg.

“We look forward to the technical expertise and logistics capabilities the Azelis team brings to delivering the products and support our Life Sciences customers need on a pan-European basis, while providing a more focused geographical approach for customers in specific paints and coatings, and other industrial markets,” said Liam Doherty, business vice president, EMEA and India.

Matthew Dickman, Azelis’ market segment director Pharma, added: “Angus and Azelis Pharma share the same focus on delivering market-specific solutions and expertise. The partnership will enable both parties to focus on providing the highest level of technical, logistical and customer service support to the growing customer base across Europe and Turkey. We are delighted to partner with Angus for this strategic business, utilising the extensive network of Azelis and the unrivalled technical and product experience of Angus to drive growth and innovation for our customers.”

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read